Peroxisome proliferator-activated receptors, orphans with ligands and functions

Current Opinion in Lipidology

Volumn 8, Issue 3, 1997, Pages 159-166

  Schoonjans, Kristina ^a   Martin, Geneviève ^a   Staels, Bart ^a   Auwerx, Johan ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CELL NUCLEUS RECEPTOR; FIBRIC ACID DERIVATIVE; GLUCOSE; HORMONE RECEPTOR; INSULIN; LEUKOTRIENE B4; LIPID; PEROXISOME PROLIFERATOR; PROSTAGLANDIN J2; THIAZOLIDINE DERIVATIVE;

ADIPOCYTE; CELL DIFFERENTIATION; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIGAND BINDING; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; MULTIGENE FAMILY; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0030794057     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199706000-00006     Document Type: Review

References (101)

1. Desvergne B, Wahli W: PPAR: a key nuclear factor in nutrient/gene interactions. In Inducible gene expression, vol 1. Edited by Bauerle P. Boston: Birkhauser: 1994:142-176.
2. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996, 1302:93-109.
3. Schoonjans K, Staels B, Auwerx J: Role of the peroxisome proliferator activated receptor (PPAR) in mediating effects of fibrates and fatty acids on gene expression. J Lipid Res 1996, 37:907-925.
4. Green S: PPAR: a mediator of peroxisome proliferator action. Mutation Res 1995, 333:101-109.
5. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W: The PPARα-leukotriene B4 pathway to inflammation control. Nature 1996, 384:39-43.
6. Hertz R, Nikodem V, Ben-Ishai A, Berman I, Bar-Tana J: Thyromimetic mode of action of peroxisome proliferators: activation of 'malic' enzyme gene transcription. Biochem J 1996, 319:241-248.
7. Ren B, Thelen A, Jump DB: Peroxisome proliferator-activated receptor a inhibits hepatic S14 gene transcription. J Biol Chem 1996, 271:17167-17173.
8. Isseman I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347:645-650.
9. Lee SST, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz PM, Fernandez PM, Westphal H, Gonzalez FJ: Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995, 15:3012-3022.
10. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors: tissue distribution of PPARα, β and γ in the adult rat. Endocrinology 1995, 137:354-366.
11. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W: Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J Biol Chem 1994, 269:24527-24530.
12. Steineger HH, Sorensen HN, Tugwood JD, Skrede S, Spydevold O, Gautvik KM: Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty acid-induced transcription. Eur J Biochem 1994, 225:967-974.
13. Staels B, Van Tol A, Andreu T, Auwerx J: Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler Thromb 1992, 12:286-294.
14. Auwerx J, Martin G, Guerre-Millo G, Staels B: Transcription, adipocyte differentiation, and obesity. J Mol Med 1996, 74:347-352.
15. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87:377-389.
16. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991, 5:1538-1552.
17. Yeh WC, Cao Z, Classon M, McKnight S: Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995, 9:168-181.
18. Wu Z, Xie Y, Bucher NLR, Farmer SR: Conditional ectopic expression of C/EBPb in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev 1995, 9:2350-2363.
19. Wu Z, Bucher NLR, Farmer SR: Induction of peroxisome proliferator-activated receptor g during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol Cell Biol 1996, 16:4128-4136.
20. Tontonoz P, Kim JB, Graves RA, Spiegelman BM: ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993, 13:4753-4759.
21. Kim JB, Spiegelman BM: ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996, 10:1096-1107.
22. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 1996, 98:1575-1584.
23. Lopez JM, Bennett MK, Sanchez HB, Rosenfeld JM, Osborne TF: Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci U S A 1996, 93:1049-1053.
24. Bennet MK, Lopez JM, Sanchez HB, Osborne TF: Sterol regulation of fatty acid synthase promoter; coordinate feedback regulation of two major lipid pathways. J Biol Chem 1995, 270:25578-25583.
25. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARg2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
26. Hu E, Tontonoz P, Spiegelman BM: Transdifferentiation of myoblasts by the adipogenic transcription factors PPARgamma and C/EBP-alpha. Proc Natl Acad Sci U S A 1995, 92:9856-9860.
27. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Hao MS, Reddy JK: Structural organization of mouse peroxisome proliferator activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci U S A 1995, 92:7921-7925.
28. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-D12,14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995, 83:803-812.
29. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehman JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995, 83:813-819.
30. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1995, 270:12953-12956.
31. Negrel R, Gaillard D, Ailhaud G: Prostacyclin as a potent effector of adipose-cell differentiation. Biochem J 1989, 257:399-405.
32. Gaillard D, Negrel R, Lagarde M, Ailhaud G: Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J 1989, 257:389-397.
33. Aubert J, Ailhaud G, Negrel R: Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells. FEBS Lett 1996, 397:117-121.
34. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996, 45:1661-1669.
35. Hulin B, McCarthy PA, Gibbs EM: The glitazone family of antidiabetic agents. Curr Pharmacol Design 1996, 2:85-102.
36. Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, Saperstein R, Smith RG, Leibewitz MD: Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-y: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 1996, 137:4189-4195.
37. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM: The structure activity relationship between peroxisome proliferator activated receptor γ agonism and the antlhyperglycemic activity of thiazolidinediones. J Med Chem 1996, 39:665-668.
38. Moller DE, Flier JS: Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 1991, 325:938-948.
39. Cornelius P, MacDougald OA, Lane MD: Regulation of adipocyte development. Annu Rev Nutr 1994, 14:99-129.
40. Mukherjee H, Davies PAJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM et al.: Sensitization of diabetic and obese mice to insulin by retinoid X receptor antagonists. Nature 1997, 386:407-410.
41. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaoga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med 1996, 2:800-803.
42. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
43. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF. Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity induced insulin resistance. Science 1996, 271:665-668.
44. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance. Endocrinology 1994, 134:264-270.
45. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 1996, 274:1185-1188.
46. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
47. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann L, Staels B, Briggs MR, Anwerx J: Thiazolidinediones repress ob gene expression via activation of PPARγ. J Clin Invest 1996, 98:1004-1009.
48. Zhang B, Graziano MP, Doebber TW, Leibowitz MD, White-Carrington S, Szalkowski DM, Hey PJ, Wu M, Cuillan CA, Bailey P, et al.: Downregulation of the expression of the obese gene by antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 1996, 271:9455-9459.
49. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Nat/Acad Sci U S A 1996, 93:5793-5796.
50. Rosen B, Cook KS, Yaglom J, Groves DL, Volonakis JE, Damm D, White T, Spiegelman BM: Adipsin and complement factor D activity: an immune-related defect in obesity. Science 1989, 244:1483-1487.
51. Frederich RC, Kahn BB, Peach MJ, Flier JS: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339-344.
52. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
53. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996, 271:10697-10703.
54. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle; its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1961, 1:785-789.
55. Schoonjans K, Peinado-Onsurbe J, Heyman R, Briggs M, Cayet D, Deeb S, Staels B, Auwerx J: PPARα and PPARγ activators direct a tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996, 15:5336-5348.
56. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Plier JS, Moller DE: Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 1996, 97:2553-2561.
57. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM: Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 1996, 10:974-984.
58. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA: The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 1996, 137:4499-4502.
59. Hu E, Kim JB, Sarraf P, Spiegelman BM: Inhibition of adipogenesis through MAP-kinase mediated phosphorylation of PPARγ. Science 1996, 274:2100-2103.
60. Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller DE: Insulin and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 1996, 271:31771-31774.
61. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM: mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994, 8:1224-1234.
62. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM: PPARg2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995, 15:351-357.
63. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, Auwerx J: Induction of the acyl-Coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 1995, 270:19269-19276.
64. Schoonjans K, Staels B, Grimaldi P, Auwerx J: Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur J Biochem 1993, 216:615-622.
65. Göttlicher M, Widmark E, Li Q, Gustafsson JA: Fatty acids activate chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1992, 89:4653-4657.
66. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W: Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliterator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A 1993, 90:2160-2164.
67. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 1994, 91:7355-7359.
68. Bocos C, Gottlicher M, Gearing K, Banner C, Enmark E, Teboul M, Crickmore A, Gustafsson JA: Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J Steroid Biochem Mol Biol 1995, 53:467-473.
69. Amri E-Z, Bertrand B, Ailhaud G, Grimaldi P: Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 1991, 32:1449-1456.
70. Chawla A, Lazar MA: Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci U S A 1994, 91:1786-1790.
71. Miller SG, De Vos P, Guerre-Millo M, Wang K, Hermann T, Staels B, Briggs MR, Auwerx J: The adipocyte specific transcription factor, C/EBPa modulates human ob gene expression. Proc Nat Acad Sd U S A 1996, 93:5507-5511.
72. He Y, Chen H, Quon MJ, Reitman M: The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem 1995, 270:28887-28891.
73. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake and insulin administration. Nature 1995, 377:527-529.
74. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-228.
75. Miller NE: Association of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987, 112:825-836.
76. Berthou L, Saladin R, Yaqoob P, Calder P, Fruchart JC, Denefle P, Auwerx J, Staels B: Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II, and acyl-CoA oxidase gene expression by fibrates and dietary fatty acids. Eur J Biochem 1995, 232:179-187.
77. Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, Guillouzo A, Fruchart J-C, Rubin E, Denèfle P, Staels B, Branellec D: Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apo A-I transgenic mice. J Clin Invest 1996, 97:2408-2416.
78. Malmendier CL, Delcroix C: Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia. Atherosclerosis 1985, 55:161-169.
79. Mellies MJ, Stein EA, Khoury P, Lamkin G, Glueck CJ: Effects of fenofibrate on lipids, lipoproteins and apolipoproteins in 33 subjects with primary hypercholesterolaemia. Atherosclerosis 1987, 63:57-64.
80. Vu-Dac N, Schoonjans K, Laine B, Fruchart JC, Auwerx J, Staels B: Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 1994, 269:31012-31018.
81. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, Staels B, Auwerx J Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 1995, 96:741-750.
82. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Heyman RA, Staels B, Auwerx J: Retinoids increase human apolipoprotein A-II expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol Cell Biol 1996, 16:3350-3360.
83. Auwerx J, Schoonjans K, Fruchart JC, Staels B: Transcriptional control of triglyceride metabolism; fibrates change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis 1996, 124(suppl):S29-S37.
84. Staels B, Vu-Dac N, Kosykh V, Saladin R, Fruchart JC, Dallongeville J, Auwerx J: Fibrates down-regulate apolipoprotein C-III expression independent of induction of peroxisomal acyl co-enzyme A oxidase. J Clin Invest 1995, 95:705-712.
85. Hertz R, Bishara-Shieban J, Bar-Tana J: Mode of action of peroxisome proliferators as hypolipidemic drugs, suppression of apolipoprotein C-III. J Biol Chem 1995, 270:13470-13475.
86. Lefebvre A-M, Peinado-Onsurbe J, Leitersdorf I, Briggs MR, Paterniti JR, Fruchart J-C, Fievet C, Auwerx J, Staels B: Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct, but complementary mechanism relative to fibrates. Arterioscler Thromb Vasc Biol 1997 (In press).
87. Bogazzi F, Hudson LD, Nikodem VM: A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferatoractivated receptor. J Biol Chem 1994, 269:11683-11686.
88. Miyata K, Zhang B, Marcus SL, Capone JP, Rachubinski RA: Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome-responsive element and antagonizes peroxisome proliferator-mediated signaling. J Biol Chem 1993, 268:19169-19172.
89. Chu R, Madison LD, Lin Y et al.: Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc Natl Acad Sci U S A 1995, 92:11593-11597.
90. Onate SA, Tsai SY, Tsai MJ, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995, 270:1354-1357.
91. Smith CL, Onate SA, Tsai MJ, O'Malley BW: CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A 1996, 93:8884-8888.
92. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Hayman RA, Rose DW, Glass CK, Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. 1996, 85(3 May):403-414.
93. Muchardt C, Yaniv M: A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 1993, 12:4279-4290.
94. Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996, 15:3667-3675.
95. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 1994, 264:1455-1458.
96. Le Douarin B, Zechel C, Gamier J-M, Lutz Y, Tora L, Pierrat B, Heary D, Gronemeyer H, Chambon P, Losson R: The N-terminal part of TIF1, a putative mediator of the ligand-dependant activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995, 14:2020-2033.
97. Chen JD, Evans RM: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
98. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995, 377:397-404.
99. Burris TP, Nawaz Z, Tsai M-J, O'Malley BW: A nuclear hormone receptor-associated protein that inhibits transactivation by thyroid hormone and retinoic acid receptors. Proc Natl Acad Sci U S A 1995, 92:9525-9529.
100. Palmer CNA, Hsu M-H, Muerhoff AS, Griffin KJ, Johnson EF: Interaction of the peroxisome proliferator-activated receptor α with the retinoid X receptor a unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter. J Biol Chem 1994, 269:18083-18089.
101. Baes M, Castelein H, Desmet L, Declercq PE: Antagonism of COUPTF and PPARα/RXRα on the activation of the malic enzyme gene promoter: modulation by 9-cis RA. Biochem Biophys Res Commun 1995, 215:338-345.